| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.00027 | 1 |